FDA: No Decision on Whether to Pull Diabetes Drug Avandia Off the
2/23/2010
HealthDay - MONDAY, Feb. 22 (HealthDay News) -- The U.S. Food and Drug
Administration on Monday said it was still reviewing affirmation that
examine whether the blockbuster type 2 insulin-dependent type i diabetes drug Avandia raises users'
odds for heart attack and heart failure and should be removed from the
market.
More: - Read More
Post Comment
Entry 1 of 16100
Last Page | Next Page









